Canagliflozin Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Drugs used in diabetes | Endocrine System
Items (12m)
53
Total Quantity
1,007
NHS Cost
£1.3K
vs National Avg
-63.1%
MAPLE ACCESS PARTNERSHIP LLP prescribed 53 items of Canagliflozin over the last 12 months at a cost of £1,256 to the NHS. This is 63.1% below the national average prescribing rate. Canagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
3
Jun 2026
2
Jun 2026
2
Jun 2026
3
Jun 2026
3
Jun 2026
3
Jun 2026
8
Jun 2026
7
Jun 2026
6
Jun 2026
4
Jun 2026
6
Jun 2026
6
Prescribing Details
| Total Items | 53 |
|---|---|
| Total Quantity | 1,007 |
| Total NHS Cost | £1,256 |
| Presentations | 2 different forms |
| vs National Average | -63.1% |
Canagliflozin Prescribing Comparison
| This practice | 53 items |
|---|---|
| National average per practice | 144 items |
| Difference | -63.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.